The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GIC Pvt Ltd
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GIC Private Limited, acting on behalf of the Government of Singapore, sold 9,846 equity shares (0.023%) of Entero Healthcare Solutions through an open market sale on 11 August 2025. This reduced GIC's holding from 1,376,407 shares (3.164%) to 1,366,561 shares (3.141%). The acquirer is not part of the promoter/promoter group and is classified as a foreign institutional investor. The disclosure under Regulation 29(2) was triggered because GIC's cumulative sales across multiple non-reportable tranches since February 2024 crossed the reporting threshold. GIC's holding has declined from 5.16% in February 2024 to 3.141% now.
This is a minor open market sale by a foreign institutional investor with no promoter involvement. The 0.023% incremental sale is small and unlikely to materially impact the stock price, but signals a continued gradual reduction of FII stake in the company.